Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Han-Seung Park, MD, Je-Hwan Lee, MD, Yoo-Jin Kim, Sang Kyun Sohn, MD, PhD, Sung-Soo Yoon, Hawk Kim, June-Won Cheong, MD, Won-Sik Lee, MD, Gyeong-Won Lee, MD, Young-Don Joo, MD, Min Kyoung Kim, MD, Yang Soo Kim, MD, Hyeoung-Joon Kim

Blood (2016) 128 (22): 1992.

https://doi.org/10.1182/blood.V128.22.1992.1992

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia in Remission - a Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors

Kyoo-Hyung Lee, MD PhD, Je-Hwan Lee, MD PhD, Jung-Hee Lee, MD PhD, Dae-Young Kim, MD PhD, Han-Seung Park, MD, Eun-Ji Choi, MD, Young-Shin Lee, MS, Young-Ah Kang, MS, Mijin Jeon, MS, Miee Seol, MS, Seung-Hyun Baek, RN, Hawk Kim, MD, Jae Hoo Park, MD, Jae-Cheol Jo, MD PhD, Yoon-Sook Choi, MD, Young-Don Joo, MD, Sung-Nam Lim, MD

Blood (2015) 126 (23): 4379.

https://doi.org/10.1182/blood.V126.23.4379.4379

Published: 2015

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Je-Hwan Lee, MD PhD, Hawk Kim, MD PhD, Young-Don Joo, MD, Won Sik Lee, Sung Hwa Bae, MD, Dae Young Zang, Jihyun Kwon, MD, Min Kyoung Kim, Junglim Lee, MD, Gyeong Won Lee, Jung-Hee Lee, MD PhD, Yunsuk Choi, MD PhD, Dae-Young Kim, MD PhD, Sung-Nam Lim, MD, Sang-Min Lee, Hun-Mo Ryoo, MD, Hyo Jung Kim, Myung Soo Hyun, Kyoo-Hyung Lee, MD PhD

Blood (2015) 126 (23): 2535.

https://doi.org/10.1182/blood.V126.23.2535.2535

Published: 2015

Journal Articles

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Sang Kyun Sohn, MD PhD, Joon Ho Moon, MD PhD, Ahn Jae Sook, MD, PhD, Hyeoung Joon Kim, MD PhD, Moo kon Song, MD, PhD, Ho-Jin Shin, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Young Don Joo, MD PhD, Ho Sup Lee, Yang Soo Kim, Yoon Young Cho, MD PhD, Sung Hwa Bae

Blood (2014) 124 (21): 3255.

https://doi.org/10.1182/blood.V124.21.3255.3255

Published: 2014

Journal Articles

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Il hwan Kim, MD, Young Don Joo, MD PhD, Joon Ho Moon, MD PhD, Sung Nam Lim, MD, Sang Kyun Sohn, MD PhD, Gyeong Won Lee, Ho Sup Lee, Ki Young Kwon, MD PhD, Sung Hyun Kim, Kyung Tae Park, Joo Seop Chung, MD PhD, Won Sik Lee, MD PhD, Sang Min Lee, MD PhD, Myung Soo Hyun, MD PhD, Hawk Kim, Hun-Mo Ryoo, MD, Sung Hwa Bae

Blood (2014) 124 (21): 2676.

https://doi.org/10.1182/blood.V124.21.2676.2676

Published: 2014

Journal Articles

Management of Patients After the Failure of Hypomethylating Treatment for Myelodysplastic Syndrome

Je-Hwan Lee, MD, PhD, Jung-Hee Lee, Yunsuk Choi, MD, Dae-Young Kim, Kyoo-Hyung Lee, MD, Sang Min Lee, Won Sik Lee, Lee Jung-Lim, Young-Don Joo, MD, PhD

Blood (2012) 120 (21): 4953.

https://doi.org/10.1182/blood.V120.21.4953.4953

Published: 2012

Journal Articles

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

Je-Hwan Lee, MD, PhD, Young-Don Joo, MD, PhD, Jung-Hee Lee, Hawk Kim, MD, Sung Hwa Bae, Min Kyung Kim, MD, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Won Sik Lee, Jae-Hoo Park, Dae-Young Kim, Sang Min Lee, Hun Mo Ryu, Myung Soo Hyun, Hyo Jung Kim, MD, PhD, Kyoo-Hyung Lee

Blood (2012) 120 (21): 3628.

https://doi.org/10.1182/blood.V120.21.3628.3628

Published: 2012

Journal Articles

Sequential High-Dose Dexamethasone and Response Adapted PAD (Bortezomib, Adriamycin, Dexamethasone) or VAD (Vincristine, Adriamycin, Dexamethasone) Chemotherapy Followed by High-Dose Therapy with ASCT for Newly Diagnosed Multiple Myeloma; Open-Labeled, Multicenter Phase 2 Study (KMM-94 Study)-Interim Analysis.

Blood (2012) 120 (21): 3106.

https://doi.org/10.1182/blood.V120.21.3106.3106

Published: 2012

Journal Articles

The Effect of Bortezomib On Bone Metabolism of Patients with Multiple Myeloma: a Korean Multicenter Prospective Study.

Chang-Ki Min, MD, Seok Jin Kim, MD, Je-Jung Lee, MD, Cheolwon Suh, MD, Jin Seok Kim, MD, Sung-Soo Yoon, MD, Byung Soo Kim, MD, Hye Jin Kang, MD, Young Jin Choi, MD, Cheol Soo Kim, MD, Yang Soo Kim, MD, Jae-Yong Kwak, MD, Yoo Jin Kim, MD, Young Don Joo, MD, Yeung-Chul Mun, MD, Deog Yeon Jo, MD, Joon Seong Park, MD, Chi-Young Park, MD, Sung Hyun Kim, MD

Blood (2009) 114 (22): 4871.

https://doi.org/10.1182/blood.V114.22.4871.4871

Published: 2009

Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Blood (2009) 114 (22): 4881.

https://doi.org/10.1182/blood.V114.22.4881.4881

Published: 2009

Journal Articles

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Blood (2007) 110 (11): 1833.

https://doi.org/10.1182/blood.V110.11.1833.1833

Published: 2007

Journal Articles

Continuous Infusion of FLAG and Idarubicin for Patients Younger Than 60 Years with Resistant Acute Myeloid Leukemia; a Prospective, Multicenter Phase II Study.

Hawk Kim, MD, PhD, Jae-Hoo Park, MD, PhD, Je-Hwan Lee, MD, PhD, Jung-Hee Lee, MD, PhD, Young-Don Joo, MD, PhD, Won-Sik Lee, MD, PhD, Sung-Hwa Bae, MD, PhD, Hun Mo Ryoo, MD, PhD, Kyoo-Hyung Lee, MD, PhD, Cooperative Study Group A for Hematology

Blood (2007) 110 (11): 4350.

https://doi.org/10.1182/blood.V110.11.4350.4350

Published: 2007

Journal Articles

Nasal Type NK/T Cell Lymphoma with Cutaneous and Ocular Involvement: A Case Report.

Ho Sup Lee, MD, Sang Min Lee, MD, Seong Hoon Shin, MD, Yang Soo Kim, MD, Young-Don Joo, MD

Blood (2007) 110 (11): 4434.

https://doi.org/10.1182/blood.V110.11.4434.4434

Published: 2007

Journal Articles

Antithymocyte Globulin (ATG) Plus Cyclosporine (CSA) for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS).

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun Hee Kim, RN, Jae-Hoo Park, MD, Hawk Kim, MD, Young-Don Joo, MD, Won-Sik Lee, MD, Dae Young Zang, MD, Hyo Jung Kim, MD, Kyoo Hyung Lee, MD

Blood (2006) 108 (11): 3777.

https://doi.org/10.1182/blood.V108.11.3777.3777

Published: 2006

Journal Articles

Prognostic Value of CD34 Expression in Patients with Acute Myeloid Leukemia Treated by Conventional Chemothearpy.

Jooseop Chung, MD, Ho-Jin Shin, MD, Young-Jin Choi, MD, Goon-Jae Cho, MD, Young-Don Joo, MD, Won-Sik Lee, MD, Eun-Yup Lee, MD, Yun-Sik Yang, MD

Blood (2005) 106 (11): 4561.

https://doi.org/10.1182/blood.V106.11.4561.4561

Published: 2005

Journal Articles

Standard Induction Followed by Attenuated Consolidation Therapy in Elderly Patients with Acute Myeloid Leukemia.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun Hee Kim, RN, Jae-Hoo Park, MD, Hawk Kim, MD, Young-Don Joo, MD, Won Sik Lee, MD, Dae Young Zang, MD, Hyo Jung Kim, MD, Kyoo-Hyung Lee, MD, Cooperative Study Group A for Hematology

Blood (2005) 106 (11): 4602.

https://doi.org/10.1182/blood.V106.11.4602.4602

Published: 2005

Journal Articles

The Incidence and Specificity of Unexpected Antibody Using Antibody Screening Test Including Di a and Mi a Cell for Korean.

Jooseop Chung, MD, Nak Hyn Sung, MD, Ho Jin Shin, MD, Goon Jae Cho, MD, Eun Yup Lee, MD, Hyung Hoi Kim, MD, Young-Don Joo, MD.

Blood (2004) 104 (11): 4102.

https://doi.org/10.1182/blood.V104.11.4102.4102

Published: 2004

NARROW

Retrospective Case Series Study of Hypomethylating Therapy in IPSS Lower-Risk Myelodysplastic Syndrome

Allogeneic Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia in Remission - a Prospective Comparison of Three Different Donor Groups; Matched Sibling, Matched Unrelated, and Haploidentical Family Donors

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia

Inferior Long-Term Outcome of Front-Line Hypomethylating Agent Compared to Supportive Care in Patients with Lower Risk Myelodysplastic Syndrome: Prosensity Score Matched Analysis

Efficacy and Safety of Deferasirox Estimated By Serum Ferritin and Labile Plasma Iron Levels in Patients with Aplastic Anemia, Myelodysplastic Syndrome, or Hematologic Malignancy with Transfusional Iron Overload

Management of Patients After the Failure of Hypomethylating Treatment for Myelodysplastic Syndrome

A Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in the Induction Chemotherapy for Acute Myeloid Leukemia: An Interim Analysis

The Effect of Bortezomib On Bone Metabolism of Patients with Multiple Myeloma: a Korean Multicenter Prospective Study.

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Preliminary Results of a Prospective Multicenter Phase III Trial Comparing High-Dose and Standard-Dose Daunorubicin for Induction of Complete Remission (CR) in Acute Myeloid Leukemia (AML).

Continuous Infusion of FLAG and Idarubicin for Patients Younger Than 60 Years with Resistant Acute Myeloid Leukemia; a Prospective, Multicenter Phase II Study.

Nasal Type NK/T Cell Lymphoma with Cutaneous and Ocular Involvement: A Case Report.

Antithymocyte Globulin (ATG) Plus Cyclosporine (CSA) for Aplastic Anemia (AA) and Low-Risk Myelodysplastic Syndrome (MDS).

Prognostic Value of CD34 Expression in Patients with Acute Myeloid Leukemia Treated by Conventional Chemothearpy.

Standard Induction Followed by Attenuated Consolidation Therapy in Elderly Patients with Acute Myeloid Leukemia.

The Incidence and Specificity of Unexpected Antibody Using Antibody Screening Test Including Di a and Mi a Cell for Korean.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only